CytomX Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC CTMX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

68,687

Value ($000)

293

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	293	0.0%	68,687	12/31/2025
2025 Q3	11/10/2025	283	0.0%	88,570	9/30/2025
2025 Q2	8/12/2025	201	0.0%	88,570	6/30/2025
2025 Q1	9/15/2025	16	0.0%	24,877	3/31/2025
2024 Q4	2/6/2025	26	0.0%	24,817	12/31/2024
2024 Q3	11/12/2024	29	0.0%	24,817	9/30/2024
2024 Q2	8/12/2024	30	0.0%	24,817	6/30/2024
2024 Q1	5/9/2024	54	0.0%	24,817	3/31/2024
2023 Q4	2/6/2024	38	0.0%	24,817	12/31/2023
2023 Q3	11/8/2023	32	0.0%	24,817	9/30/2023
2023 Q2	8/10/2023	43	0.0%	24,817	6/30/2023
2023 Q1	5/12/2023	37	0.0%	24,817	3/31/2023
2022 Q4	2/13/2023	68	0.0%	42,221	12/31/2022
2022 Q3	11/14/2022	62	0.0%	42,221	9/30/2022
2022 Q1	5/13/2022	447	0.0%	167,178	3/31/2022
2021 Q4	2/11/2022	711	0.0%	164,014	12/31/2021
2021 Q3	11/16/2021	837	0.0%	164,258	9/30/2021
2021 Q2	8/16/2021	3,228	0.0%	509,929	6/30/2021
2021 Q1	5/17/2021	3,815	0.0%	493,509	3/31/2021
2020 Q4	2/16/2021	2,323	0.0%	354,643	12/31/2020
2020 Q3	11/13/2020	2,150	0.0%	323,242	9/30/2020
2020 Q2	8/20/2020	2,728	0.0%	327,404	6/30/2020
2020 Q1	5/15/2020	2,174	0.0%	283,323	3/31/2020
2019 Q4	2/7/2020	2,124	0.0%	255,479	12/31/2019